Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia
about
Unique ligand-binding property of the human IgM Fc receptor.GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6.Immunotherapy in pediatric malignancies: current status and future perspectivesIgG Subclasses and Isotypes of VH4-34 Encoded Antibodies.The new ParaDIgm: IgM from bench to clinic: November 15-16, 2011, Frankfurt, Germany.Ovarian carcinoma glyco-antigen targeted by human IgM antibody.
P2860
Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Phase I trial of a novel human ...... l acute lymphoblastic leukemia
@ast
Phase I trial of a novel human ...... l acute lymphoblastic leukemia
@en
type
label
Phase I trial of a novel human ...... l acute lymphoblastic leukemia
@ast
Phase I trial of a novel human ...... l acute lymphoblastic leukemia
@en
prefLabel
Phase I trial of a novel human ...... l acute lymphoblastic leukemia
@ast
Phase I trial of a novel human ...... l acute lymphoblastic leukemia
@en
P2093
P2860
P1433
P1476
Phase I trial of a novel human ...... l acute lymphoblastic leukemia
@en
P2093
Bruno C Medeiros
Caroline Berube
Clare J Twist
Jason R Gotlib
Marcia M Bieber
Michaela Liedtke
Neelima M Bhat
Nelson N Teng
Steven E Coutre
P2860
P356
10.3324/HAEMATOL.2011.045997
P577
2011-10-11T00:00:00Z